Goldman Sachs Group Inc Oncolytics Biotech Inc Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 208,698 shares of ONCY stock, worth $219,132. This represents 0.0% of its overall portfolio holdings.
Number of Shares
208,698
Previous 130,198
60.29%
Holding current value
$219,132
Previous $100,000
192.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ONCY
# of Institutions
58Shares Held
2MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY383KShares$402,5130.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il382KShares$401,1530.0% of portfolio
-
Marshall Wace, LLP London, X0324KShares$340,1810.0% of portfolio
-
Seeds Investor LLC New York, NY258KShares$271,2210.08% of portfolio
-
International Assets Investment Management, LLC Orlando, FL207KShares$217,2450.01% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $60.8M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...